“Crux Biolabs have been critical to help Pio Therapeutics advance our lead program, and meet key pre-clinical value inflection points through the development of bioanalytical and primary cell-based functional assays. In all instances, Crux executed the work with a high degree of expertise, rigour and flexibility.”